• Importing medicine from Canada's or other countries' drug supplies isn't safe or cost-effective.

  • More than a decade into the counterfeit pill crisis, fake prescription pills made with deadly ingredients are still killing Americans. 

  • Overwhelming demand for transformative GLP-1s has led to widespread illicit compounding and a boom in counterfeiting.

  • Several states are trying to to set price caps to reduce the cost of expensive medicine, but this could bankrupt pharmacies and threaten patient access.

Prescription Drug Freight Fraud Report, April 2026

April 27, 2026

What do FDA records of GLP-1 and antibiotic imports show about freight fraud patterns over the last six months?

What’s master carton smuggling?

April 27, 2026

In March, customs officers in Cincinnati announced the seizure of thousands of shipments of GLP-1s and other peptides packaged inside more than 300 “master cartons” with deceptive manifests meant to slip into the country unnoticed. Curious how this smuggling scheme works? Read on.

April 20, 2026: Maryland becomes the second state to set a drug price cap

April 21, 2026

The Jardiance upper payment limit, based on the Medicare maximum fair price, is set to take effect in 2027.

April 13, 2026: New video shows Mochi Health-affiliated pharmacy’s “corner cutting”

April 14, 2026

A newly-released March 2025 Washington State Department of Health video shows investigators raiding Aequita, where “cutting corners [was seen] at nearly every level of its operation.”

The FDA speaks up about AFPs and drug importation

April 8, 2026

Is personal drug importation legal in the context of alternative funding programs? The FDA says no.

Are self-funded health plans allowed to import medicine because of “Section 804” or “Florida’s importation plan”? Also, no.

April 6, 2026: Over 200 patients bought unapproved imported peptides from a now-indicted Utah physician

April 7, 2026

The doctor allegedly bought the unapproved drugs through a middleman and relabeled them before selling them to patients.

March 30, 2026: A second pharmacy benefit manager settles suit with the FTC over insulin price inflation

March 31, 2026

CVS Health’s Caremark deal mirrors the deal the FTC struck with Express Scripts last month, a person familiar with the case told Reuters.

Like your information on video? Subscribe to our YouTube playlist!

youtube-video-thumbnail

Troubling practices alleged at a compounding pharmacy that supplied glp-1s.  Learn more.

youtube-video-thumbnail

Congressman Krishnamoorthy is looking into GLP-1 drugs that may be entering the US unlawfully.

youtube-video-thumbnail

A recent FDA warning letter highlights upstream supply chain vulnerabilities.

Click the images below to see more recent videos.